CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 14 enrolled
Drug / intervention
Dark chocolatedietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04847999
NCT04847999N/ACompleted

Impact of Dark Chocolate Consumption on Glucose Levels of People With Diabetes

University of British Columbia·interventional·Posted Apr 19, 2021·Updated Feb 27, 2025

In Brief

A clinical study evaluating Dark chocolate for Type 2 Diabetes and Type 1 Diabetes. Completed, enrolled 14 participants across 1 site.

Detailed Summary

Diabetes is a growing concern in the world with an estimated 9.3% of adults, ages 20-79, with it in 2019, type 2 diabetes accounting for 90% of this total. A common recommendation for individuals with diabetes is to limit sugars and sweets as it may cause a high blood glucose response. As a result, chocolate is often avoided due to the sugar content; though, high-polyphenol chocolate may have a beneficial effect on hyperglycaemia and vascular function. The sugar-free chocolate from Ross Chocolates is formulated with a blend of inulin, erythritol, and stevia. These alternatives to sugar are not expected to cause a significant change in blood glucose levels following consumption. The main objective of this study is to verify glucose levels before and after consumption of Ross Chocolates' blend of sweeteners dark chocolate and conventional chocolate in people with diabetes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCanada
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedApr 19, 2021
Enrollment StartNov 20, 2020
Primary CompletionMay 4, 2021
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 5.2 years ago

Interventions

Dark chocolatedietary

Dark chocolate